COCO Insider Sales: Martin Roper Disposes 20,000 Shares Under 10b5-1
Rhea-AI Filing Summary
Martin Roper, CEO and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock on 09/12/2025 executed under a Rule 10b5-1 trading plan. The filing shows four sell transactions of 5,000 shares each at weighted-average prices around $40.01, reducing the reporting person's direct beneficial ownership to 352,062 shares. Separate lines show indirect holdings of 286,131 shares held by each of three family trusts and 61,200 shares held by a spouse. The form also discloses multiple fully vested and outstanding non-qualified stock options with various exercise prices and vesting schedules, including options exercisable for 579,670 shares and others vesting through 2035.
Positive
- Sales were executed under a Rule 10b5-1 trading plan, indicating pre-arranged dispositions rather than opportunistic trades
- Reporting person retains substantial equity and option holdings, including a fully vested option covering 579,670 shares
Negative
- Insider sold 20,000 shares on 09/12/2025, reducing direct ownership to 352,062 shares
Insights
TL;DR: Insider sales under a 10b5-1 plan reduced direct holdings but left substantial equity and many vested options.
The Form 4 documents systematic sales totaling 20,000 common shares on 09/12/2025, executed pursuant to a Rule 10b5-1 plan, at weighted-average prices near $40. These transactions lowered the reporting person's direct stake to 352,062 shares while sizable indirect holdings remain via family trusts and spouse. The filing also lists large option positions, including a fully vested option covering 579,670 shares exercisable at $10.178 and multiple other option tranches with exercise prices through $32.78 and vesting into 2035. For investors, this shows liquidity-taking by an insider without elimination of meaningful ownership and with substantial option-based incentives remaining.
TL;DR: Sales appear routine and pre-planned; continued indirect family holdings and long-dated options indicate ongoing alignment.
The filing explicitly states the sales were made under a Rule 10b5-1 trading plan, which typically signals pre-arranged, non-tactical dispositions. Direct ownership was reduced to 352,062 shares while identical indirect balances (286,131) are reported for three family trusts, and 61,200 shares are held by a spouse, reflecting concentrated family ownership. Multiple non-qualified stock options—including a large fully vested tranche—remain outstanding, preserving incentive alignment. No amendments or unusual disclosures are present in the form.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $40.015 | $200K |
| Sale | Common Stock | 5,000 | $40.008 | $200K |
| Sale | Common Stock | 5,000 | $40.005 | $200K |
| Sale | Common Stock | 5,000 | $40.019 | $200K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Peter S. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
